Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Industry Scores a Win as Watered-Down Version of Canada's IRP Reform Unveiled in Final Guidelines, but Prices Will Nevertheless Decline" report has been added to ResearchAndMarkets.com's offering.
Shortly after the release of Canada's long-awaited final guidelines for the implementation of its International Reference Pricing (IRP) system reform, The analyst reflects on how the final reform compares to the original plans and where the real danger to the pharma industry lies as the new rules take effect.
Key Topics Covered:
- Key findings
- The history of a much-delayed IRP reform
- Role of IRP in pricing process
- An unexpected positive for pharma in the final guidelines
- Disclaimer
For more information about this report visit https://www.researchandmarkets.com/r/y0zjid
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
